✨ Medicinal Product Consents




2764 NEW ZEALAND GAZETTE, No. 102 20 SEPTEMBER 2007

Product:
Clopine
Active Ingredient:
Clozapine 50mg
Dosage Form:
Tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Douglas Manufacturing Limited, Lincoln, Auckland

Note: This consent is given subject to the following conditions:

  • The medicine may only be prescribed by:
    • registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified
      by the Medical Council of New Zealand as competent in the scope of practice of psychiatry; and
    • medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the
      kind referred to above.
  • Persons prescribing the medicine must comply with appropriate local treatment guidelines.
  • The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
  • Sale or marketing of this medicine may only occur if:
    • the sponsor has an appropriate blood monitoring and patient record database in place; and
    • the sponsor creates or participates in a central "red flag" database identifying patients who have previously been
      prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated.

Note: This consent is valid for two years from 13 January 2007.


Product:
Clozaril
Active Ingredient:
Clozapine 100mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Note: This consent is given subject to the following conditions:

  • The medicine may only be prescribed by:
    • registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified
      by the Medical Council of New Zealand as competent in the scope of practice of psychiatry; and
    • medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the
      kind referred to above.
  • Persons prescribing the medicine must comply with appropriate local treatment guidelines.
  • The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
  • Sale or marketing of this medicine may only occur if:
    • the sponsor has an appropriate blood monitoring and patient record database in place; and
    • the sponsor creates or participates in a central "red flag" database identifying patients who have previously been
      prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated.

Note: This consent is valid for two years from 4 February 2007.


Product:
Clozaril
Active Ingredient:
Clozapine 25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Note: This consent is given subject to the following conditions:

  • The medicine may only be prescribed by:
    • registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified
      by the Medical Council of New Zealand as competent in the scope of practice of psychiatry; and
    • medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the
      kind referred to above.
  • Persons prescribing the medicine must comply with appropriate local treatment guidelines.
  • The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
  • Sale or marketing of this medicine may only occur if:
    • the sponsor has an appropriate blood monitoring and patient record database in place; and
    • the sponsor creates or participates in a central "red flag" database identifying patients who have previously been
      prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated.

Note: This consent is valid for two years from 4 February 2007.


Product:
Zopine
Active Ingredient:
Clozapine 100mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia

Note: This consent is given subject to the following conditions:



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 102


Gazette.govt.nz PDF NZ Gazette 2007, No 102





✨ LLM interpretation of page content

πŸ₯ Amendment to the Conditions of Provisional Consent to the Distribution of Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines, Clopine, Clozapine, Provisional Consent, Distribution, Prescription Guidelines

πŸ₯ Provisional Consent for Clopine (Clozapine 50mg Tablet)

πŸ₯ Health & Social Welfare
Medicines, Clopine, Clozapine, Provisional Consent, Distribution, Prescription Guidelines

πŸ₯ Provisional Consent for Clozaril (Clozapine 100mg Tablet)

πŸ₯ Health & Social Welfare
Medicines, Clozaril, Clozapine, Provisional Consent, Distribution, Prescription Guidelines

πŸ₯ Provisional Consent for Clozaril (Clozapine 25mg Tablet)

πŸ₯ Health & Social Welfare
Medicines, Clozaril, Clozapine, Provisional Consent, Distribution, Prescription Guidelines

πŸ₯ Provisional Consent for Zopine (Clozapine 100mg Tablet)

πŸ₯ Health & Social Welfare
Medicines, Zopine, Clozapine, Provisional Consent, Distribution, Prescription Guidelines